Cartilage metabolism diseases—including osteoarthritis, inflammatory arthritides, and hereditary chondrodysplasias—require sensitive biomarkers to track cartilage breakdown and repair. At Southern Medical Supplies Limited (SMSL), we offer targeted panels measuring type II collagen degradation and synthesis markers (e.g., urinary CTX-II, C2C/C1,2C neoepitopes, CPII/PIIANP), cartilage matrix components (aggrecan fragments, COMP), joint turnover and inflammatory mediators (hyaluronic acid, MMP-3, with adjunct CRP/ESR), and optional genetic/molecular assays where inherited etiologies are suspected. Our solutions span ELISA, chemiluminescent immunoassay, molecular, and clinical chemistry platforms sourced from a broad network of trusted partners—EUROIMMUN, Ansh Labs, Randox, Streck, Bio-Rad, Abbott, Roche, Siemens Healthineers, Qiagen, bioMérieux, Cepheid, Werfen, Globe Scientific, ELGA LabWater, LW Scientific, Sebia, LTA SRL, Acrobiotech, MAKOL Innovacion Medica, Rayto Life and Analytical Sciences, Diazyme, Hardy’s Diagnostics, and Teco Diagnostics—delivering the analytical sensitivity, specificity, and reproducibility clinicians need to diagnose, phenotype, monitor progression, and assess response to therapy in cartilage disorders.